UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30, p.ii14-ii15

2019

Volltextzugriff (PDF)

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30, p.ii15-ii16

2019

Volltextzugriff (PDF)

Uma tradução comentada do artigo “A Termodinâmica Oculta das Partículas” de Louis de Broglie

Revista Brasileira de Ensino de Física, 2021, Vol.43

2021

Volltextzugriff (PDF)

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8636-8645

2005

Volltextzugriff (PDF)

1501PImpact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

Annals of oncology, 2019-10, Vol.30, p.v616

2019

Volltextzugriff (PDF)

1501P - Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

Annals of oncology, 2019-10, Vol.30, p.v616-v616

2019

Volltextzugriff (PDF)

44PTemporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S700-S700

2018

Volltextzugriff (PDF)

P09.42 Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S309-S310

2021

Volltextzugriff (PDF)

P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S812-S812

2019

Volltextzugriff (PDF)

Ampere's motor: Its history and the controversies surrounding its working mechanism

American journal of physics, 2012-11, Vol.80 (11), p.990-995

2012

Volltextzugriff (PDF)

45PTreatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Parametric numerical study of the flow and heat transfer in microchannel with dimples

International communications in heat and mass transfer, 2016-08, Vol.76, p.348-357

2016

Volltextzugriff (PDF)

P2.12-19 Small Cell Lung Cancer (SCLC) Treatment and Survival in Portugal: An IPO-PORTO Analysis from the I-O Optimise Initiative

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S820-S821

2019

Volltextzugriff (PDF)

92 - Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S38-S38

2018

Volltextzugriff (PDF)

Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S38

2018

Volltextzugriff (PDF)

Electrical and thermal conductivities and Seebeck coefficient of liquid copper-bismuth alloys

Philosophical magazine (Abingdon, England), 2009-01, Vol.89 (3), p.249-262

2009

Volltextzugriff (PDF)

PRM69 - I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

Value in health, 2017-10, Vol.20 (9), p.A742-A743

2017

Volltextzugriff (PDF)

I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

Value in health, 2017-10, Vol.20 (9), p.A742-A743

2017

Volltextzugriff (PDF)

Electronic transport properties in the liquid 3d transition-metal series

Philosophical magazine. B, Physics of condensed matter. Structural, electronic, optical, and magnetic properties., 2002-05, Vol.82 (8), p.875-889

2002

Volltextzugriff (PDF)

Electrical resistivity and absolute thermoelectric power of liquid copper–lead alloys

Physica. B, Condensed matter, 1998-07, Vol.252 (1), p.106-113

1998

Volltextzugriff (PDF)

Weekly paclitaxel (PCT) in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8044-8044

2004

Volltextzugriff (PDF)

Weekly paclitaxel (PCT) in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8044-8044

2004

Volltextzugriff (PDF)

Electrical and thermal conductivities and Seebeck coefficient of liquid copper–bismuth alloys

Philosophical magazine (Abingdon, England), 2009-01, Vol.89 (3), p.249-262

2009

Volltextzugriff (PDF)

1 – 25 von 528

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(364)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Uma tradução comentada do artigo “A Termodinâmica Oculta das Partículas” de Louis de Broglie

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

1501PImpact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

1501P - Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative

44PTemporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database

P09.42 Second-Line Immunotherapy Treatment Patterns in Non-Small Cell Lung Cancer in Portugal: An I-O Optimise Cohort Study

P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative

Ampere's motor: Its history and the controversies surrounding its working mechanism

45PTreatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Parametric numerical study of the flow and heat transfer in microchannel with dimples

P2.12-19 Small Cell Lung Cancer (SCLC) Treatment and Survival in Portugal: An IPO-PORTO Analysis from the I-O Optimise Initiative

92 - Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database

Clinical characteristics and overall survival of patients diagnosed with non-small cell lung cancer (NSCLC) between 2006 and 2017 in routine clinical practice: a retrospective analysis of a UK hospital database

Electrical and thermal conductivities and Seebeck coefficient of liquid copper-bismuth alloys

PRM69 - I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

Electronic transport properties in the liquid 3d transition-metal series

Electrical resistivity and absolute thermoelectric power of liquid copper–lead alloys

Weekly paclitaxel (PCT) in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02)

Weekly paclitaxel (PCT) in non-small cell lung cancer (NSCLC): Results in older or frail patients. A Spanish Lung Cancer Group Trial (GECP 00-02)

Electrical and thermal conductivities and Seebeck coefficient of liquid copper–bismuth alloys

Suchergebnisse filtern